The global cancer drugs market is surging toward $594.3 billion by 2035 as high-tech immunotherapies begin to replace ...
News-Medical.Net on MSN
Low-dose megestrol strengthens hormone therapy in ER-positive breast cancer
Low-dose megestrol enhances hormone therapy for ER-positive breast cancer, reducing tumor proliferation and improving ...
The rich are increasingly looking for properties that can accommodate extended families. Mllennials and Gen Xers are driving ...
Researchers developed a way to directly reprogram human glial cells into PV interneurons without passing through a stem‑cell stage.
For years, progress in robotics has followed a familiar pattern. Researchers train increasingly powerful ...
Espervita Therapeutics, a biotechnology company developing targeted metabolic reprogramming therapies, announced the publication in Cell Metabolism of groundbreaking preclinical data demonstrating ...
THE proposed 2026 budget for the Cebu Provincial Government will not be approved just yet after local lawmakers agreed to ...
Scientists at Stanford Medicine have reported a discovery that could change how arthritis and joint damage are treated. In ...
The minibus spending package generally seeks modest spending reductions for covered agencies, but departs from the Trump ...
Congress has unveiled a new package of bills to fund some agencies through fiscal 2026, the latest bipartisan breakthrough as ...
Many organisms have an amazing capacity to adapt to conditions of low oxygen, but the cellular mechanisms of this are poorly understood. A new study in mice has unveiled a molecular trigger that ...
ME Therapeutics Holdings Inc. will attend the 44th annual JP Morgan Healthcare Conference from January 12 to 15, 2026 in San ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results